Abstract:Hypoxia is a hallmark of solid tumors. Hypoxic cancer cells adjust their metabolic characteristics to regulate the production of cellular reactive oxygen species (ROS) and facilitate ROS‐mediated metastasis. Peroxisome proliferator‐activated receptor γ (PPARγ) is a nuclear receptor that regulates the transcription of fatty acid metabolism‐related genes that have a key role in the survival and proliferation function of hypoxic cancer cells. In the present study, mRNA expression in HepG2 cells under chemically induced hypoxia was assessed. The protein expression levels of hypoxia‐inducible factor 1α (HIF‐1α) were measured using western blotting. Following treatment with the PPARγ agonist pioglitazone, cell viability was assessed using a Cell Counting Kit‐8 assay, whilst cell proliferation and death were determined using 5‐ethynyl‐2'‐deoxyuridine incorporation staining, and calcein‐acetoxymethyl ester and propidium iodide staining, respectively. Cellular ROS production was assessed using dihydroethidium staining. Cobalt chloride was used to induce hypoxia in HepG2 cells, which was evaluated using HIF‐1α expression. The results revealed that the mRNA expression of PPARγ, CD36, acetyl‐co‐enzyme A dehydrogenase (ACAD) medium chain (ACADM) and ACAD short‐chain (ACADS) was downregulated in hypoxic HepG2 cells. The PPARγ agonist pioglitazone decreased the cell viability of hypoxic HepG2 cells by inhibiting cell proliferation and inducing cell death. Following treatment with the PPARγ agonist pioglitazone, hypoxic HepG2 cells produced excessive ROS. ROS‐mediated cell death induced by the PPARγ agonist pioglitazone was rescued with the antioxidant N‐acetyl‐L‐cysteine. The downregulated mRNA expression of PPARγ, CD36, ACADM and ACADS was not reverted by a PPARγ agonist in hypoxic HepG2 cells. By contrast, the PPARγ agonist suppressed the mRNA expression of BCL2, which was upregulated in hypoxic HepG2 cells. In summary, the PPARγ agonist stimulated excessive ROS production to inhibit cell proliferation and increase the death of hypoxic HepG2 cells by decreasing BCL2 mRNA expression, suggesting a negative association between PPARγ and BCL2 in the regulation of ROS production in hypoxic HepG2 cells.

Peroxisome Proliferator-Activated Receptor Γ (Ppar-Γ) Agonist Rosiglitazone (RGZ) Inhibits HL-60 Cell Growth by Induction of Apoptosis

Peroxisome Proliferator-Activated Receptor-Gamma Agonist Rosiglitazone-Induced Apoptosis In Leukemia K562 Cells And Its Mechanisms Of Action

Peroxisome Proliferator-Activated Receptor-γ Agonist Rosiglitazone– Induced Apoptosis in Leukemia K562 Cells and Its Mechanisms of Action

Rosiglitazone attenuates endothelial progenitor cell apoptosis induced by TNF-α via ERK/MAPK and NF-κB signal pathways.

Pro-apoptotic effect of ciglitazone in leukemic HL-60 cells via PPARγ and P38 MAPK signaling pathway

Effect of rosiglitazone on proliferation of U937 cells and its mechanisms

Anti‐proliferative Effect of Rosiglitazone in the Human T‐lymphocyte Leukaemia Cell Line Jurkat Cells

Its Mechanisms of Action Induced Apoptosis in Leukemia − Agonist Rosiglitazone γ Peroxisome Proliferator-Activated Receptor -

Effects of PPARγ Ligand Rosiglitazone on AGS Gastric Cancer Cells Growth

Activation of Peroxisome Proliferator-Activated Receptor-Gamma Induces Apoptosis on Acute Promyelocytic Leukemia Cells Via Downregulation of XIAP.

Effects of Rosiglitazone on Proliferation,apoptosis and Expression of PTEN and Survivin in Liver Cancer Cell Line SMMC-7721

Growth inhibition and differentiation induced by peroxisome proliferator activated receptor gamma ligand rosiglitazone in human melanoma cell line A375

Rosiglitazone attenuates hypoxia-induced renal cell apoptosis by inhibiting NF-κB signaling pathway in a PPARγ-dependent manner

[Proliferation and Apoptosis Effect of Rosiglitazone on Human Ovarian Cancer Cell Line SKOV3].

Mechanistic Study of Peroxisome Proliferator-Activated Receptor γ(PPARγ) Agonist Induced Apoptosis of NB4 Cells

Activation of PPARγ inhibits cells growth of colorectal carcinoma via inducing cell apoptosis and cell cycle arrest

Pioglitazone, a peroxisome proliferator‐activated receptor γ agonist, induces cell death and inhibits the proliferation of hypoxic HepG2 cells by promoting excessive production of reactive oxygen species

Expression of Survivin and Bax/bcl-2 in Peroxisome Proliferator Activated Receptor-Γ Ligands Induces Apoptosis on Human Myeloid Leukemia Cells in Vitro

Rosiglitazone Inhibits Lymph Node Metastasis of Non-small Cell Lung Cancer and Induces Apoptosis of Bronchogenic Carcinoma by Down-regulating IGF-1 Expression

Inhibitory effect of rosiglitazone on colon cancer cells in vitro

Inhibition of Lymphoma Cell Proliferation by Peroxisomal Proliferator-Activated Receptor-γ Ligands via Wnt Signaling Pathway